Pte. Postema et al., [IN-111-DTPA-D-PHE(1)]OCTREOTIDE SCINTIGRAPHY IN THYROIDAL AND ORBITAL GRAVES-DISEASE - A PARAMETER FOR DISEASE-ACTIVITY, The Journal of clinical endocrinology and metabolism, 79(6), 1994, pp. 1845-1851
Visualization of malignant lymphomas and granulomatous disease is poss
ible by [In-111-DTPA-D-Phe(1)]octreotide scintigraphy through binding
of the radioligand to somatostatin receptors on activated leukocytes.
Because thyroidal and orbital tissues are infiltrated by activated leu
kocytes in Graves' disease, a cross-sectional study to visualize disea
se activity with [In-111-DTPA-D-Phe(1)]octreotide scintigraphy was per
formed. A correlation between thyroidal [In-111-DTPA-D-Phe1]octreotide
accumulation and free T-4 (disease expression) and thyroid binding-in
hibiting immunoglobulins (disease activity) is present in untreated hy
perthyroid Graves' disease. There is also a correlation between orbita
l [In-111-DTPA-D-Phe(1)]octreotide uptake and the clinical activity sc
ore (disease activity) and total eye score (disease expression), respe
ctively, in Graves' orbitopathy. Visualization of thyroidal and orbita
l Graves' disease is feasible, but further investigation is necessary
to establish the role of [In-111-DTPA-D-Phe(1)]octreotide scintigraphy
in representing disease activity and expression and in predicting the
rapeutical outcome.